3-methylcholanthrene has been researched along with Carcinoma, Lewis Lung in 4 studies
Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.
Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Two animal tumor models were used: fibrosarcoma induced by 3-methylcholanthrene (3-MCA) in FVB/N mice invalidated for AT2R (AT2R-KO) and carcinoma LL/2 cells injected in C57BL/6N mice treated with AT2R antagonist PD123,319." | 3.76 | Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis. ( Chalopin, M; Clere, N; Coqueret, O; Corre, I; Delneste, Y; Faure, S; Guihot, AL; Hein, L; Henrion, D; Morel, A; Paris, F; Vessières, E, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clere, N | 1 |
| Corre, I | 1 |
| Faure, S | 1 |
| Guihot, AL | 1 |
| Vessières, E | 1 |
| Chalopin, M | 1 |
| Morel, A | 1 |
| Coqueret, O | 1 |
| Hein, L | 1 |
| Delneste, Y | 1 |
| Paris, F | 1 |
| Henrion, D | 1 |
| Manegold, PC | 1 |
| Hutter, J | 1 |
| Pahernik, SA | 1 |
| Messmer, K | 1 |
| Dellian, M | 1 |
| Kovalchin, JT | 1 |
| Murthy, AS | 1 |
| Horattas, MC | 1 |
| Guyton, DP | 1 |
| Chandawarkar, RY | 1 |
| Hardy, B | 1 |
| Yampolski, I | 1 |
| Kovjazin, R | 1 |
| Galli, M | 1 |
| Novogrodsky, A | 1 |
4 other studies available for 3-methylcholanthrene and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Deficiency or blockade of angiotensin II type 2 receptor delays tumorigenesis by inhibiting malignant cell proliferation and angiogenesis.
Topics: Angiotensin II Type 2 Receptor Blockers; Animals; Carcinoma, Lewis Lung; Cell Growth Processes; Cell | 2010 |
Platelet-endothelial interaction in tumor angiogenesis and microcirculation.
Topics: Animals; Blood Flow Velocity; Blood Platelets; Calcimycin; Calcium; Carcinoma, Lewis Lung; Cell Move | 2003 |
Determinants of efficacy of immunotherapy with tumor-derived heat shock protein gp96.
Topics: Adjuvants, Immunologic; Animals; Antigens, Neoplasm; Antigens, Surface; Carcinoma, Lewis Lung; Combi | 2001 |
A monoclonal antibody against a human B lymphoblastoid cell line induces tumor regression in mice.
Topics: Animals; Antibodies, Monoclonal; B-Lymphocytes; Carcinoma, Lewis Lung; Cells, Cultured; Fibrosarcoma | 1994 |